235 related articles for article (PubMed ID: 22125617)
1. Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates.
Kamath S; Chavez AO; Gastaldelli A; Casiraghi F; Halff GA; Abrahamian GA; Davalli AM; Bastarrachea RA; Comuzzie AG; Guardado-Mendoza R; Jimenez-Ceja LM; Mattern V; Paez AM; Ricotti A; Tejero ME; Higgins PB; Rodriguez-Sanchez IP; Tripathy D; DeFronzo RA; Dick EJ; Cline GW; Folli F
PLoS One; 2011; 6(11):e27617. PubMed ID: 22125617
[TBL] [Abstract][Full Text] [Related]
2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
3. Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics.
Smith GI; Polidori DC; Yoshino M; Kearney ML; Patterson BW; Mittendorfer B; Klein S
J Clin Invest; 2020 Jun; 130(6):3305-3314. PubMed ID: 32191646
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI.
Gonzalez-Cantero J; Martin-Rodriguez JL; Gonzalez-Cantero A; Arrebola JP; Gonzalez-Calvin JL
PLoS One; 2018; 13(2):e0192663. PubMed ID: 29425212
[TBL] [Abstract][Full Text] [Related]
5. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
Lomonaco R; Ortiz-Lopez C; Orsak B; Webb A; Hardies J; Darland C; Finch J; Gastaldelli A; Harrison S; Tio F; Cusi K
Hepatology; 2012 May; 55(5):1389-97. PubMed ID: 22183689
[TBL] [Abstract][Full Text] [Related]
6. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
[TBL] [Abstract][Full Text] [Related]
7. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.
Deivanayagam S; Mohammed BS; Vitola BE; Naguib GH; Keshen TH; Kirk EP; Klein S
Am J Clin Nutr; 2008 Aug; 88(2):257-62. PubMed ID: 18689359
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of intrahepatic triglyceride accumulation.
Ress C; Kaser S
World J Gastroenterol; 2016 Jan; 22(4):1664-73. PubMed ID: 26819531
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV; Hevener AL; Farese RV
Cell Metab; 2007 Jul; 6(1):69-78. PubMed ID: 17618857
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
12. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1131-e1139. PubMed ID: 33347566
[TBL] [Abstract][Full Text] [Related]
13. Acyl-Coenzyme A Thioesterase 9 Traffics Mitochondrial Short-Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver.
Steensels S; Qiao J; Zhang Y; Maner-Smith KM; Kika N; Holman CD; Corey KE; Bracken WC; Ortlund EA; Ersoy BA
Hepatology; 2020 Sep; 72(3):857-872. PubMed ID: 32498134
[TBL] [Abstract][Full Text] [Related]
14. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
15. Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease.
Rodríguez A; Gena P; Méndez-Giménez L; Rosito A; Valentí V; Rotellar F; Sola I; Moncada R; Silva C; Svelto M; Salvador J; Calamita G; Frühbeck G
Int J Obes (Lond); 2014 Sep; 38(9):1213-20. PubMed ID: 24418844
[TBL] [Abstract][Full Text] [Related]
16. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.
Fabbrini E; Mohammed BS; Korenblat KM; Magkos F; McCrea J; Patterson BW; Klein S
J Clin Endocrinol Metab; 2010 Jun; 95(6):2727-35. PubMed ID: 20371660
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance.
Zhang D; Liu ZX; Choi CS; Tian L; Kibbey R; Dong J; Cline GW; Wood PA; Shulman GI
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17075-80. PubMed ID: 17940018
[TBL] [Abstract][Full Text] [Related]
18. Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals.
Saponaro C; Sabatini S; Gaggini M; Carli F; Rosso C; Positano V; Armandi A; Caviglia GP; Faletti R; Bugianesi E; Gastaldelli A
Liver Int; 2022 Nov; 42(11):2418-2427. PubMed ID: 35900229
[TBL] [Abstract][Full Text] [Related]
19. [The unity of pathogenesis of insulin resistance syndrome and non-alcoholic fatty disease of liver. The metabolic disorder of fatty acids and triglycerides].
Titov VN; Ivanova KV; Malyshev PP; Kaba SI; Shiriaeva IuK
Klin Lab Diagn; 2012 Nov; (11):3-12. PubMed ID: 23305008
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis.
Koo SH
Clin Mol Hepatol; 2013 Sep; 19(3):210-5. PubMed ID: 24133660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
